Laser Resurfacing Versus Dermabrasion for Scar Revision
NCT ID: NCT01176448
Last Updated: 2019-11-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2010-04-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microneedling vs Dermabrasion for Early Facial Scar Resurfacing
NCT06171386
Carboxytherapy in the Treatment of Atrophic Scars
NCT05695807
The Efficacy of Combination Therapy in Atrophic Scars
NCT06298591
The Effects of Microdermabrasion on Skin Remodeling
NCT00111254
Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy
NCT02985151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fractionated laser
This Arm is the section of scar that will be treated with Fractionated Laser
Fractionated laser
Fractionated laser in the form of the Re:Pair CO2 laser manufactured by Solta Medical.
Dermabrasion
Dermabrasion is the gold standard for scar resurfacing and will be used as the control against which Fractionated Laser is compared.
Dermabrasion
Diamond Fraise Dermabrasion will be performed in standard fashion down to papillary dermis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fractionated laser
Fractionated laser in the form of the Re:Pair CO2 laser manufactured by Solta Medical.
Dermabrasion
Diamond Fraise Dermabrasion will be performed in standard fashion down to papillary dermis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 or older
* Able to read and comprehend English
* Willing to follow treatment schedule and post treatment care requirements
* Signed the informed consent form
* Fitzpatrick skin type I-III
Exclusion Criteria
* Taken any medications known to induce photosensitivity in previous three months
* Taken Accutane within past 12 months
* Pregnant or nursing
* Currently on topical or oral antibiotics
* Immunocompromised status
* Skin type IV or greater
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John J Christophel, MD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zel Skin and Laser
Edina, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jared Christophel J, Elm C, Endrizzi BT, Hilger PA, Zelickson B. A randomized controlled trial of fractional laser therapy and dermabrasion for scar resurfacing. Dermatol Surg. 2012 Apr;38(4):595-602. doi: 10.1111/j.1524-4725.2011.02283.x. Epub 2012 Jan 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1001M75732-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.